Rebuilding Pharma's Image: How Would Bill Clinton Do It?
|
|
May 2010
By: Sander A. Flaum in Med Ad News
One of the most powerful strategic tools is still the old-fashioned thought experiment what if. What if Steve Jobs had not returned to Apple? What if he had never left? Without expressing any lack of confidence in the current CEO, what would happen if an entirely different personality were in charge of PhRMA? Say Bill Clinton?.
Read this article |
|
Great Expectations
|
|
March 2010
By: Sander A. Flaum in Med Ad News
When the General Motors board of directors ousted Fritz Henderson from his new job as CEO in December, he had not yet been on the job eight full months. But it took no more time than that for GMs board to judge and dismiss Henderson and install Chairman Ed Whitacre as the interim CEO. (Whitacre has since been named Hendersons permanent replacement.)
Read this article
|
|
MULTITASKING HAS HAD ITS FIFTEEN MINUTES OF FAME
|
|
February 2010
By: Sander A. Flaum in Med Ad News
When President Obama took office in January of last year, he won early praise for taking on a variety of hot-button issues during his first days on the job. He ordered the closure of the American prison at Guantanamo Bay. He drew up new regulations for financial companies. He issued a climate change agenda and committed to healthcare reform. He proposed new rules for lobbying in Washington. And he held six meetings with his economic team in his first days on the job.
Read this article |
|
READ, WATCH, LISTEN!
|
|
January 2010
By: Sander A. Flaum in Med Ad News
Inventive thinking has always been the price of entry into the big leagues of business, but now more leaders are beginning to realize that developing new methods of raising revenue or controlling costs is what separates top-tier businesses from mediocre ones.
Read this article |
|
THE DISRUPTIVE INNOVATOR
|
|
December 2009
By: Sander A. Flaum in Med Ad News
When we think about innovators who have changed their fields, we tend to focus on the leaders of older, established companies who pushed through big changes such as Steve Jobs and Bill Gates. Too often, we overlook the pharmaceutical sector, forgetting the accomplishments of some truly imaginative leaders. One of those leaders is Fred Hassan, the chairman and chief executive of Schering-Plough, which is merging with Merck.
Read this article |
|
TIME TO TAKE SOME RISKS
|
|
November 2009
By: Sander A. Flaum in Pharmaceutical Executive
The economy is turning around; leaders need to position their companies now for the market bounce.
Read this article |
|
STRENGTHENING BRAND AMERICA
|
|
An Expert Interview with Sander Flaum - Strategic Marketing Expert
Read this article |
|
STOP THE HARD STOP
|
|
October 2009
By: Sander A. Flaum in Pharmaceutical Executive
Leaders manage their time and focus their resources by limiting unwanted interruptions.
Read this article |
|
UPCLOSE WITH SANDER FLAUM, CEO OF FLAUM PARTNERS
|
|
August 2009
By: Paula Silverman in PM360
After decades of experience as a product manager and, eventually, Marketing Director at Lederle Laboratories, this industry veteran rose to become chairman of pharmaceutical advertising agency Euro RSCG Life. In total, he has directed more than 70 product launches and restagings. PM360 recently spoke with Sander Flaum about what young product managers must do to rise through the corporate ranks, the subject of his next book, due out this fall.
Read this article |
|
LEMONADE 101
|
|
August 2009
By: Sander A. Flaum in Pharmaceutical Executive
Business schools must prepare students for the post-recession economy, not teach them principles applicable to 2003.
Read this article |
|
TIME TO CREATE
|
|
July 2009
By: Sander A. Flaum in Pharmaceutical Executive
Too many people think of creativity as a mystic flash of inspiration. Its also hard work that needs to be built into every leaders professional life.
Read this article |
|
|